High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

Abstract Background Breast cancer anti-estrogen resistance 1 (BCAR1/p130cas) is a hub for diverse oncogenic signaling cascades and promotes tumor development and progression. Methods To understand the effect of BCAR1 in prostate cancer, we analyzed its expression on more than 11,000 prostate cancer...

Full description

Bibliographic Details
Main Authors: Asmus Heumann, Nina Heinemann, Claudia Hube-Magg, Dagmar S. Lang, Katharina Grupp, Martina Kluth, Sarah Minner, Christina Möller-Koop, Markus Graefen, Hans Heinzer, Maria Christina Tsourlakis, Waldemar Wilczak, Corinna Wittmer, Frank Jacobsen, Hartwig Huland, Ronald Simon, Thorsten Schlomm, Guido Sauter, Stefan Steurer, Patrick Lebok, Andrea Hinsch
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Cancer
Subjects:
BCAR1
Prostate cancer
Tissue microarray
Prognosis
Immunohistochemistry
Online Access:http://link.springer.com/article/10.1186/s12885-017-3956-3

Internet

http://link.springer.com/article/10.1186/s12885-017-3956-3

Similar Items